Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | LMAT | SOLV |
|---|---|---|
| Price | $80.99 | $88.03 |
| Change today | ▲ 2.57% | ▲ 0.20% |
| Market cap | $1.85B | $14.98B |
| Return, 3 months | -23.1% | +15.4% |
| Return, year to date | +0.6% | +11.1% |
| Return, 1 year | -6.5% | +19.3% |
| P/E (TTM) | 28.3 | 10.8 |
| P/B | 4.4 | 3.1 |
| P/E percentile vs own 5y | 2nd | 46th |
| Dividend yield | 1.11% | – |
| Revenue growth (YoY, latest qtr) | – | +2.2% |
| Net profit growth (YoY) | – | +3.3% |
| Gross margin | – | 54.7% |
| Operating margin | – | 6.3% |
| Net margin | – | 17.3% |
| Return on equity | – | 34.0% |
| Analyst target vs. price | +32.7% | +11.6% |
| Analyst buy share | 67% | 70% |
| RSI (14) | 48 | 47 |
| 30-day volatility | 20.4% | 17.0% |
| Max drawdown, 1 year | -32.5% | -27.5% |
| Trend read | Leaning bearish | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
